DuPont de Nemours, Inc.

XTRA:6D81 Stock Report

Market Cap: €27.9b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

DuPont de Nemours Valuation

Is 6D81 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6D81 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

€116.57
Fair Value
44.5% undervalued intrinsic discount
16
Number of Analysts

Below Fair Value: 6D81 (€64.74) is trading below our estimate of fair value (€116.57)

Significantly Below Fair Value: 6D81 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6D81?

Key metric: As 6D81 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 6D81. This is calculated by dividing 6D81's market cap by their current revenue.
What is 6D81's PS Ratio?
PS Ratio2.6x
SalesUS$12.61b
Market CapUS$32.75b

Price to Sales Ratio vs Peers

How does 6D81's PS Ratio compare to its peers?

The above table shows the PS ratio for 6D81 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1x
1COV Covestro
0.8x2.41%€11.4b
SY1 Symrise
2x4.07%€10.1b
EVK Evonik Industries
0.5x1.75%€6.4b
WCH Wacker Chemie
0.6x2.34%€3.4b
6D81 DuPont de Nemours
2.6x2.75%€32.8b

Price-To-Sales vs Peers: 6D81 is expensive based on its Price-To-Sales Ratio (2.6x) compared to the peer average (1x).

Price to Sales Ratio vs Industry

How does 6D81's PS Ratio compare vs other companies in the DE Chemicals Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
7M8 EcoRub
0.08xn/aUS$49.61m
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
6D81 2.6xIndustry Avg. 1.0xNo. of Companies3PS00.40.81.21.62+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 6D81 is expensive based on its Price-To-Sales Ratio (2.6x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is 6D81's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6D81 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.6x
Fair PS Ratio1x

Price-To-Sales vs Fair Ratio: 6D81 is expensive based on its Price-To-Sales Ratio (2.6x) compared to the estimated Fair Price-To-Sales Ratio (1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6D81 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€79.37
0%
8.33%€97.16€68.18n/a16
Nov ’26n/a
€79.37
0%
8.33%€97.16€68.18n/a16
Oct ’26€64.74
€79.32
+22.53%
8.33%€97.11€68.14n/a16
Sep ’26€66.26
€76.30
+15.15%
15.26%€97.32€40.12n/a16
Aug ’26€62.24
€74.42
+19.57%
14.47%€96.21€40.02n/a17
Jul ’26€60.50
€72.77
+20.29%
15.04%€95.85€39.87n/a18
Jun ’26€59.21
€74.93
+26.55%
15.07%€99.53€41.40n/a19
May ’26€57.53
€75.25
+30.79%
17.98%€101.53€41.14n/a19
Apr ’26€69.46
€90.29
+29.98%
14.86%€107.52€43.56n/a18
Mar ’26€77.88
€93.97
+20.67%
13.59%€111.85€50.14n/a18
Feb ’26€73.68
€91.46
+24.14%
14.50%€111.48€49.97n/a17
Jan ’26€73.13
€93.21
+27.45%
14.24%€111.46€49.97n/a16
Dec ’25€79.48
€90.72
+14.14%
13.22%€101.12€49.14n/a16
Nov ’25€76.24
€87.64
+14.95%
13.16%€97.27€48.17n/a17
Oct ’25€79.76
€83.90
+5.19%
13.20%€94.30€46.70€64.7417
Sep ’25€75.47
€84.69
+12.22%
13.14%€95.49€47.29€66.2617
Aug ’25€76.02
€85.32
+12.24%
13.00%€97.30€48.19€62.2417
Jul ’25€75.32
€83.12
+10.36%
13.12%€95.37€48.15€60.5017
Jun ’25€74.63
€83.12
+11.38%
13.12%€95.37€48.15€59.2117
May ’25€68.46
€74.59
+8.95%
11.95%€84.18€48.64€57.5316
Apr ’25€71.20
€70.27
-1.30%
13.30%€92.54€48.12€69.4616
Mar ’25€64.36
€70.39
+9.36%
13.04%€93.38€48.56€77.8816
Feb ’25€56.78
€70.17
+23.58%
13.38%€92.33€48.01€73.6816
Jan ’25€69.40
€72.77
+4.85%
12.36%€83.62€44.54€73.1316
Dec ’24€66.60
€71.63
+7.55%
12.80%€83.75€44.60€79.4816
Nov ’24€64.52
€74.83
+15.98%
14.78%€87.06€46.37€76.2417
€77.08
Fair Value
16.0% undervalued intrinsic discount
16
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/02 21:58
End of Day Share Price 2025/09/26 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DuPont de Nemours, Inc. is covered by 40 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William SeleskyArgus Research Company
Patrick Duffy FischerBarclays
Michael LeitheadBarclays